attia glp 1 320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape - The Peter Drive 246 - AMA #45: Pros

Hyperuricemia versus lifestyle in men and women of the Russian Federation population

Gold nanoparticles for biology and medicine

Its very exciting, but its a bit scary because were moving forward without all the data. Mental illness Obesity correlates with an increased risk of developing many mental health issues, including depression, anxiety, and bipolar disorder

Elevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumors

The $63-billion GLP-1 agonist industry is forecast to triple in the coming decade, so it's no surprise that pharmaceuticals companies of all sizes are scrambling to get in on the action